Association between thyroid function and Alzheimer's disease: A systematic review
Open accessThe DOI matches its Crossref record; 104 of the 104 references it cites were found in a registry or an index.
Abstract
Alterations in metabolic parameters have been associated with an increased risk of dementia, among which thyroid function has gained great importance in Alzheimer's disease (AD) pathology in recent years. However, it remains unclear whether thyroid dysfunctions could influence and contribute to the beginning and/or progression of AD or if it results from AD. This systematic review was conducted to examine the association between thyroid hormone (TH) levels and AD. Medline, ISI Web of Science, EMBASE, Cochrane library, Scopus, Scielo, and LILACS were searched, from January 2010 to March 2020. A total of 17 articles were selected. The studies reported alterations in TH and circadian rhythm in AD patients. Behavior, cognition, cerebral blood flow, and glucose consumption were correlated with TH deficits in AD patients. Whether thyroid dysfunctions and AD have a cause-effect relationship was inconclusive, however, the literature was able to provide enough data to corroborate a relationship between TH and AD. Although further studies are needed in this field, the current systematic review provides information that could help future investigations.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For example, the levels of tetraiodothyronine (T4) and triiodothyronine (T3) decrease in elderly individuals, resulting in AD-related reducion in blood perfusion in memory-related regions and decrease in energy supply to the CNS due to low glucose metabolism.360,361”
From Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances (2025) · cites this paper as [361]
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & The PRISMA Group (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000097 · Cited by 64,042
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.005 · Cited by 18,657
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
Jack, C. R., Bennett, D. A., Blennow, K., Carrillo, M. C., Dunn, B., Haeberlein, S. B., Holtzman, D. M., Jagust, W., Jessen, F., Karlawish, J., et al. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.02.018 · Cited by 10,537
Sperling, R. A., Aisen, P. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, A. M., Iwatsubo, T., Jack, C. R., Kaye, J., Montine, T. J., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.003 · Cited by 7,155
Román, G. C., Tatemichi, T. K., Erkinjuntti, T., Cummings, J. L., Masdeu, J. C., Garcia, J. H., Amaducci, L., Orgogozo, J.-M., Brun, A., Hofman, A., et al. (1993) · Neurology · doi:10.1212/wnl.43.2.250 · Cited by 4,921
Overdependence on degraded gist memory in Alzheimer's disease.
Gallo, D. A., Shahid, K. R., Olson, M. A., Solomon, T. M., Schacter, D. L., & Budson, A. E. (2006) · Neuropsychology · doi:10.1037/0894-4105.20.6.625 · Cited by 4,732
Hollowell, J. G., Staehling, N. W., Flanders, W. D., Hannon, W. H., Gunter, E. W., Spencer, C. A., & Braverman, L. E. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.2.489 · Cited by 4,279
Research works printed but not linked: 1
- Abdul-Rahman SA, Al Saied SS, Aly WW, Bastawy SA (2013) Dementia, thyroid function and serum level of S100B. Life Sci J 10:2633–2638
Cited by
Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances
Jiang, Q., Liu, J., Huang, S., Wang, X.-Y., Chen, X., Liu, G.-H., Ye, K., Song, W., Masters, C. L., Wang, J., et al. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02145-7 · Cited by 165
“360,361 Moreover, elevated levels of circulating luteinizing hormone (LH) during ageing process impair BDNF expression and synaptic plasticity.”
Pathophysiology and Clinical Features of Neuropsychiatric Manifestations of Thyroid Disease
Jurado-Flores, M., Warda, F., & Mooradian, A. D. (2022) · Journal of the Endocrine Society · doi:10.1210/jendso/bvab194 · Cited by 124
“Thyroid hormones may have a role in the pathogenesis of Alzheimer disease [85] through oxidative stress, inflammation [86, 87], and alterations in the splicing of the β-amyloid precursor protein isoforms [88].”
BackgroundSawicka-Gutaj, N., Zawalna, N., Gut, P., & Ruchała, M. (2022) · Pharmacological Reports · doi:10.1007/s43440-022-00377-w · Cited by 57
“This may be explained by the effects of hypothyroidism, which include an increase in vascular resistance disrupting the function of the brain, or an indirect influence of TH on AD [89, 95].”
BackgroundThe Role of Thyroid Dysfunction in Alzheimer's Disease: A Systematic Review and Meta-Analysis
Salehipour, A., Dolatshahi, M., Haghshomar, M., & Amin, J. (2023) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2023.20 · Cited by 49
“Whether hyper- or hypothyroidism is directly linked with AD remains unclear (37-39).”
BackgroundThyroid Dysfunction and Risk of Parkinson’s Disease: A Systematic Review and Meta-Analysis
Charoenngam, N., Rittiphairoj, T., Ponvilawan, B., & Prasongdee, K. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.863281 · Cited by 38
Metadata
- Authors
- Figueroa, P. B. S., Ferreira, A. F. F., Britto, L. R., Doussoulin, A. P., & Torrão, A. D. S.
- Affiliations
- Universidad de La Frontera (CL)
- Universidade de São Paulo (BR)
- Corresponding author
- Figueroa, Paulina Belén Sepulveda
- Ferreira, Ana Flávia Fernandes
- ORCID
- Venue
- Metabolic Brain Disease
- Published
- 2021-06-19
- Volume
- 36
- Issue
- 7
- Pages
- 1523-1543
- ISSN
- 0885-7490 (ISSN-L)
- 1573-7365
- OpenAlex
- W3171960996
- Cited by
- 28
- References
- 104
- Citations by year
- 2026: 3 · 2025: 6 · 2024: 6 · 2023: 4 · 2022: 7 · 2021: 2
- FWCI
- 0.85
- Type
- journal article
- Language
- en
- Open access
- green
- repositorio.ufro.cl
- Licence
- cc-by-nc-nd
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Metabolic Brain Disease (publishedVersion)
- PubMed (publishedVersion)
- Omeka S (Universidad de La Frontera) (submittedVersion, cc-by-nc-nd)
- Funders
- FAPESP (2020/02109-3)
- ANID (72190107)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- Alzheimer's disease, thyroid function, thyroid hormones, thyroid dysfunction, dementia risk, circadian rhythm, cognitive impairment, cerebral blood flow, glucose metabolism, disease progression
- MeSH terms
- Alzheimer Disease, Circadian Rhythm, Humans, Thyroid Diseases, Thyroid Hormones, Thyrotropin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Association between thyroid function and Alzheimer's disease: A systematic review. https://app.cochat.ai/papers/10.1007/s11011-021-00760-1
- The paper
- Figueroa, P. B. S., Ferreira, A. F. F., Britto, L. R., Doussoulin, A. P., & Torrão, A. D. S. (2021). Association between thyroid function and Alzheimer's disease: A systematic review. Metabolic Brain Disease. https://doi.org/10.1007/s11011-021-00760-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.